Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mak

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cell Metabolism|May 9, 2006
Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signalingCharles Y Cho, Seung-Hoi Koo, Yan Wang, et al.
Current Chemical Genomics|February 18, 2010
Cellular Ser/Thr-kinase assays using generic peptide substratesDeanna G Adams, Yu Wang, Puiying A Mak, et al.
ACS Infectious Diseases|May 19, 2015
A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin ProteinKris M White, Paul De Jesus, Zhong Chen, et al.
Journal of Medicinal Chemistry|August 2, 2007
N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbetaValentina Molteni, Xiaolin Li, Juliet Nabakka, et al.
Nature Medicine|October 10, 2018
Structure-guided combination therapy to potently improve the function of mutant CFTRsGuido Veit, Haijin Xu, Elise Dreano, et al.
British Journal of Anaesthesia|June 17, 2019
Duration of EEG suppression does not predict recovery time or degree of cognitive impairment after general anaesthesia in human volunteersB P Shortal, L B Hickman, R A Mak-McCully, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2023
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)Jocelyn Wang, Kohki M Nakafuku, Jeannie Ziff, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2024
Building social equity and person-centred innovation into the end TB responseN Engel, I Apolosi, A Bhargava, et al.
Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cell Metabolism|May 9, 2006
Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signalingCharles Y Cho, Seung-Hoi Koo, Yan Wang, et al.
Current Chemical Genomics|February 18, 2010
Cellular Ser/Thr-kinase assays using generic peptide substratesDeanna G Adams, Yu Wang, Puiying A Mak, et al.
ACS Infectious Diseases|May 19, 2015
A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin ProteinKris M White, Paul De Jesus, Zhong Chen, et al.
Journal of Medicinal Chemistry|August 2, 2007
N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbetaValentina Molteni, Xiaolin Li, Juliet Nabakka, et al.
Nature Medicine|October 10, 2018
Structure-guided combination therapy to potently improve the function of mutant CFTRsGuido Veit, Haijin Xu, Elise Dreano, et al.
British Journal of Anaesthesia|June 17, 2019
Duration of EEG suppression does not predict recovery time or degree of cognitive impairment after general anaesthesia in human volunteersB P Shortal, L B Hickman, R A Mak-McCully, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2023
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)Jocelyn Wang, Kohki M Nakafuku, Jeannie Ziff, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2024
Building social equity and person-centred innovation into the end TB responseN Engel, I Apolosi, A Bhargava, et al.
Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Pageof 9